Promino Nutritional Sciences Inc (MUSLF)
Promino Nutritional Sciences, Inc. engages in the production, distribution, and marketing of consumer-packaged nutritional products. It operates through the Canada and United States geographical segments. Its products include JAKTRX and Rejuvenate. The company was founded by Stuart Lowther on June 25, 2018 and is headquartered in Burlington, Canada.
Sector: Packaged Foods
Industry: Packaged Foods
Promino Nutritional Sciences Inc
OTC:MUSLFConsumer Defensive · Packaged Foods
-6.12%$0.0138
CLOSED · Nov 16Prev close$0.0147-6.12%Close$0.0138
Mkt Cap$2.97M
EV$4.23M
Float213.15M
O/S215.18M
VOL5K sh
$ Vol$72
RVOL0.06×
Inst Own-
SI0.1%
Net Cash/Sh-$0.01
Dilution
MCap$2.97MFloat213.15MO/S215.18M
Dilution
Financials Summary
Revenue$1.51M
Net Income-$2.1M
Total Assets$141K
Free Cash Flow-$895K
Debt & Equity
Total Debt$1.28M
Total Equity-$5.54M
Shares Outstanding
Short Interest
Split History1 split · 1 reverse
- 1:3Reverse splitApr 1, 20243 shares → 1
Balance Sheet Details
Assets$141K
Liabilities$5.68M
Accounts Receivable$21K
Accounts Payable$4.24M
Inventory$83K
PP&E (Net)$0
Goodwill$0
Intangible Assets$0
Income Statement
| Period | FY 2025 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|
| Currency | USD | USD | USD | USD |
| Period Ending | 2025-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 |
| Revenue | $1.51M | $2.8M | $1.65M | $686K |
| YoY Growth | -46.2% | 69.8% | 140.6% | - |
| Cost of Revenue | $1.19M | $3.56M | $1.53M | $572K |
| Gross Profit | $314K | -$758K | $122K | $114K |
| Gross Margin | 20.9% | -27.1% | 7.4% | 16.6% |
| Research and Development | $13K | $13K | $11K | $30K |
| Selling, General, and Administrative | $2.4M | $6.47M | $7.1M | $2.6M |
| Other | $0 | $24K | $57K | $105K |
| Total Operating Expenses | $2.41M | $6.51M | $7.17M | $2.74M |
| Operating Income (EBIT) | -$2.1M | -$7.27M | -$7.05M | -$4.15M |
| Operating Margin | -139.3% | -259.5% | -427.1% | -605.6% |
| Interest Expense | $214K | $94K | $19K | $21K |
| Interest Income | $0 | $0 | $0 | $0 |
| Other Income (Expense) | $4K | $25K | $900K | -$1.25M |
| Income Before Tax (EBT) | -$2.1M | -$7.24M | -$6.15M | -$5.4M |
| Income Tax Expense | $0 | $0 | $0 | $0 |
| Net Income | -$2.1M | -$7.24M | -$6.15M | -$5.4M |
| Net Income Margin | -139.1% | -258.6% | -372.5% | -787.9% |
| Supplementary Data | ||||
| EPS | -0.02 | -0.10 | -0.10 | -0.09 |
| Diluted EPS | -0.02 | -0.10 | -0.10 | -0.09 |
| Weighted Average OS | 136.31M | 107.00M | 83.62M | 87.24M |
| EBITDA | -$1.88M | -$7.01M | -$6.03M | -$6.76M |
| EBITDA Margin | -124.9% | -250.3% | -365.7% | -986.3% |
Balance Sheet
| Period | FY 2025 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|
| Currency | USD | USD | USD | USD |
| Period Ending | 2025-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 |
| Assets | ||||
| Current Assets | ||||
| Cash and Cash Equivalents | $17K | $2K | $345K | $61K |
| Short-Term Investments | $1K | $0 | $0 | $0 |
| Cash and Short-Term Investments | $18K | $2K | $345K | $61K |
| Accounts Receivable | $21K | $628K | $299K | $439K |
| Inventory | $83K | $1.01M | $2.24M | $239K |
| Other Current Assets | $0 | $146K | $565K | $54K |
| Total Current Assets | $141K | $1.79M | $3.44M | $793K |
| Long-Term Assets | ||||
| Property, Plant & Equipment Net | $0 | $65K | $54K | $117K |
| Goodwill | $0 | $0 | $0 | $0 |
| Intangible Assets | $0 | $0 | $0 | $0 |
| Long-Term Investments | $0 | $0 | $0 | $0 |
| Deferred Tax Assets | $0 | $0 | $0 | $0 |
| Other Long-Term Assets | $0 | $0 | $0 | $0 |
| Total Long-Term Assets | $0 | $65K | $54K | $117K |
| Other Assets | $0 | $0 | $0 | $0 |
| Total Assets | $141K | $1.86M | $3.5M | $910K |
| Liabilities | ||||
| Current Liabilities | ||||
| Accounts Payable | $4.24M | $4.1M | $2.08M | $1.7M |
| Short-Term Debt | $1.28M | $1.01M | $485K | $888K |
| Current Income Tax Payable | $0 | $0 | $0 | $0 |
| Current Unearned Revenue | $0 | $0 | $0 | $0 |
| Other Current Liabilities | $161K | $140K | $0 | $0 |
| Total Current Liabilities | $5.68M | $5.25M | $2.56M | $2.59M |
| Long-Term Liabilities | ||||
| Long-Term Debt | $0 | $18K | $20K | $73K |
| Long-Term Unearned Revenue | $0 | $0 | $0 | $0 |
| Long-Term Deferred Tax Liabilities | $0 | $0 | $0 | $0 |
| Other Long-Term Liabilities | $0 | $0 | $0 | $0 |
| Total Long-Term Liabilities | $0 | $18K | $20K | $73K |
| Other Liabilities | $0 | $0 | $0 | $0 |
| Total Liabilities | $5.68M | $5.26M | $2.58M | $2.66M |
| Stockholders' Equity | ||||
| Preferred Stock | $0 | $0 | $0 | $0 |
| Common Stock | $23.28M | $16.78M | $14.32M | $7.65M |
| Retained Earnings | -$34.44M | -$23.17M | -$15.93M | -$9.78M |
| Comprehensive Income & Other | -$367K | -$269K | -$45K | $42K |
| Other Stockholders' Equity | $5.62M | $2.98M | $2.53M | $382K |
| Total Equity | -$5.54M | -$3.41M | $913K | -$1.75M |
| Minority Interest | $0 | $0 | $0 | $0 |
| Total Liabilities and Equity | $141K | $1.86M | $3.5M | $910K |
| Supplementary Data | ||||
| Total Debt | $1.28M | $1.03M | $505K | $961K |
| Net Debt | $1.26M | $1.03M | $161K | $900K |
Cash Flow Statement
| Period | FY 2025 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|
| Currency | USD | USD | USD | USD |
| Period Ending | 2025-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 |
| Operating Activities | ||||
| Net Income | -$2.09M | -$7.24M | -$6.15M | -$5.4M |
| Depreciation & Amortization | $0 | $24K | $57K | $108K |
| Deferred Income Tax | $0 | $428K | -$1.1M | $0 |
| Stock-Based Compensation | $0 | $693K | $1.1M | $0 |
| Changes in Working Capital: | ||||
| Accounts Receivable | $76K | $0 | $0 | $0 |
| Inventory | $403K | $950K | -$1.98M | -$37K |
| Accounts Payable | $761K | $0 | $0 | $0 |
| Other Working Capital | -$3K | $1.98M | $6K | $740K |
| Total Working Capital Change | $1.24M | $2.93M | -$1.97M | $703K |
| Other Non-Cash Items | -$37K | $19K | $1.1M | $3.08M |
| Net Cash from Operating | -$895K | -$3.15M | -$6.96M | -$1.51M |
| Investing Activities | ||||
| Capital Expenditures | $0 | -$16K | -$26K | -$7K |
| Acquisitions | $0 | $0 | $0 | $0 |
| Purchases of Investments | -$27K | $0 | $0 | $0 |
| Sales of Investments | $196K | $0 | $0 | $0 |
| Other Investing Activities | $0 | $2K | $0 | $1.3M |
| Net Cash from Investing | $168K | -$14K | -$26K | $1.29M |
| Financing Activities | ||||
| Debt Repaid | - | - | - | - |
| Common Stock Issuance | $585K | $2.45M | $8.49M | $0 |
| Common Stock Repurchases | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Financing Activities | $55K | $3.01M | $7.38M | $155K |
| Net Cash from Financing | $640K | $3.01M | $7.38M | $155K |
| Forex Effect | $6K | -$184K | -$115K | $46K |
| Net Change in Cash | -$81K | -$342K | $283K | -$12K |
| Supplementary Data | ||||
| Operating Cash Flow | -$895K | -$3.15M | -$6.96M | -$1.51M |
| Capital Expenditure | $0 | -$16K | -$26K | -$7K |
| Free Cash Flow | -$895K | -$3.17M | -$6.99M | -$1.51M |
| Cash at Beginning | $98K | $345K | $61K | $73K |
| Cash at End | $17K | $2K | $345K | $61K |